Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy.
D000293:Adolescent; D000328:Adult; D000740:Anemia / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003248:Constipation / Q000139:chemically induced; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D003556:Cystitis / Q000139:chemically induced; D003609:Dactinomycin / Q000009:adverse effects / Q000627:therapeutic use; D004338:Drug Combinations; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D006801:Humans; D007223:Infant; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D009365:Neoplasm Regression, Spontaneous; D011867:Radioisotope Teletherapy; D012075:Remission, Spontaneous; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D013280:Stomatitis / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use
D004338:Drug Combinations; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide